News
A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...
in my engineering experience waaaayyyy overkill....I can’t get over what a well made car it seems to be....sorry for Corporate US manufacturers.... The Mercedes-Benz SL-Class price depends on ...
In a year in which it received a record number of applications for the incoming first-year class, Boston College continued to solidify its status as one of the country’s most selective universities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results